Risks Involved With ALLOGENIC (Cells NOT from your body) Stem Cell Therapy While additional research is underway to further assess the safety and efficacy of stem cell treatment for COPD and other diseases, there are certain risks that have been clearly identified, primarily with ALLOGENIC (Cells NOT from your body) stem cell
HOPE IS JUST A 30 MINUTE FLIGHT
AWAY FROM SOUTH FLORIDA!
• graft versus host disease
• tumor formation
• inappropriate migration of cells to other areas of the body
• immune system rejection
What the “So Called” Stem Cell Clinics for lung disease will sell you in the USA is a PRP (Plasma Rich platelets) treatment. NOT Stem Cell Therapy. Manipulation of cells is NOT regulated or approved by the FDA.
Okyanos Stem Cell Therapy SCT utilizes processed adult stem cells harvested and isolated from the patient’s own Adipose (Fat) that are then infused into the patient intravenously.
The adipose tissue is then processed by the Tissue Genesis ICellator, a state of the art, single-use, sterile, automated system that isolates a potent and pure mixture of mesenchymal stem cells and endothelial progenitor cells that have the ability to heal/repair/help the damaged tissue. Once in the body, they slow down the diseases progression, decreasing inflammation, scar formation, and preventing continued cellular death, while at the same time, promoting tissue perfusion and the repair and replacement of damaged lung tissue.
NO graft versus host disease
NO tumor formation
NO inappropriate migration of cells to other areas of the body
NO immune system rejection
Stem Cell Therapy brings real hope to many patients who have exhausted other forms of COPD and lung disease conventional options.
Before considering stem cell therapy, however, do your homework. There are clinics out there just waiting to take advantage of desperate people. No medical clinic in the U. S. will currently provide stem cell therapy with manipulation for COPD or any other type of lung disease, though some medical institutions may enroll patients with COPD into research studies on stem cell therapy. If you participate in such a study, make sure it is approved by the review board of the institution. Learning all you can about the risks and benefits involved will enable you to make an informed decision and one that is best for you and your family.
In Plain English:
What the “So Called” Stem Cell Clinics for lung disease will sell you in the USA is a PRP treatment.
Do not expect any meaningful sustained improvement when implanted with PRP (Platelet-Rich Plasma) . The cells obtained by this bedside 15 minute spinning procedure are simply NOT powerful enough to achieve any relevant therapeutic results. The studies are conclusive.
Okyanos Center of Excellence
Just 10 minutes by car from the Grand Bahama International Airport (FPO), it is located in downtown Freeport on peaceful Grand Bahama Island.
Bahamas is one of the few places where SCT is LEGAL and REGULATED.
HOPE IS JUST A 30 MINUTES FLIGHT AWAY FROM SOUTH FLORIDA!
Frequency of treatments:
Depending on how you will react to the treatment and physical therapy thereafter, it is entirely up to you to repeat the treatment. We only use autologous cells (your own) so you can repeat treatment as many times as you desire; it can’t hurt you. Some patients get much better and thus get excited to go for a reinforcement treatment after a year +, the majority do not need it from our experience in 7 years of long term follow up.
Our clinical research director always follows up with all our patients after treatment. You will continue seeing your doctor in USA and taking medicine as prescribed by him. As you improve it is up to him to adjust your dose.
We have not seen any ill side effects, only overall improvements of other unrelated conditions. We strive to educate our patients for them to understand what to expect from treatment.
What is the prognosis and life expectancy for a person with COPD?
• For people with mild COPD (stage I) the prognosis is very good and they may have a relatively normal life expectancy but this decreases as the severity of staging increases.
• People with COPD who are admitted to an ICU have an estimated death rate of about 24% and this rate can double for people over age 65.
• The average life expectancy of a COPD patient who undergoes a lung transplant is about five years. (This is with the hopes of no complications)
• SCT is an EXCELLENT alternative to Lung transplant.
Lung Disease Information
Yes. There is Hope
Rejuvenare’s medical board reviews every case to qualify a prospective patient. You will NOT be invited for treatment unless we feel strongly you will benefit from SCT. We reject all prospects that will not meet our criteria. We have treated over 400 COPD patients safely and efficaciously, utilizing our proprietary cell processing protocols and consistently meeting or exceeding our therapeutic expectations.
Rejuvenare’s proprietary processing of the stem cells has now consistently achieved the therapeutic expectations. However, that is just 50% of the therapy. The other 50% is the delivery protocols from our pioneer doctors tested, adjusted, and retested to reach the desired optimized therapeutic effect.
Stem Cell Therapy For Lung Disease
Most of our COPD patients require a single implant of cells to achieve the therapeutic effect; however for no-option patients and pulmonary fibrosis patients we strongly suggest a minimum of two implants, regardless of how well they feel after the first SCT.
There is no down time as all is done with local anesthesia.
The ready-processed cells are delivered directly to the arm vein following Rejuvenare’s revolutionary delivery protocols.
Stem Cell therapy starts after a 20-minute harvesting procedure of adult stem cells from the patient’s Adipose (Mesenchymal Stem Cells and Endothelial Progenitor Cells, CD34+) via small liposuction performed with local anesthesia and conscious sedation. The adipose tissue is then processed by the Tissue Genesis ICellator, a state of the art, single-use, sterile, automated system that isolates a potent and pure mixture of mesenchymal stem cells and endothelial progenitor cells that have the ability to heal/repair/help the damaged heart tissue by minimizing inflammation, preventing further cardiac cell death and inducing the growth and proliferation of new blood vessels that enhance tissue perfusion. We deliver stem cells into the main vein of the heart through a cardiac catheterization procedure done in our state-of-the-art catheterization lab. This procedure only affects the patient’s veins; therefore, minimal recovery is necessary and only immediately after the procedure.
What does stem cell therapy do for COPD?
Adult stem cells can be thought of as “small doctors” that live inside our bodies taking care of normal every day wear-and-tear bumps and bruises. Their job is to heal and repair the body on a daily basis creating and regenerating tissue. For example, if you cut your finger, it is these cells that will tend to the wound and create new skin.
Although our lungs possess their own population of healing adult stem cells, there are simply not enough cells present in that location to keep up with the degree of ongoing lung tissue damage that occurs in COPD.
As backed by years of research and Rejuvenare’s own experience, stem cells harvested from the adipose tissue, and later processed in our lab creates the most potent Stem Cells ready for implantation which can be immediately put to work to provide cellular repair to the damage found in lungs as a result of COPD.
Once your own processed healing cells are implanted many things will happen at once; They will target and generally stop the slow the degenerative progression of COPD while at the same time restoring normal blood flow, drastically reducing inflammation throughout the system and regenerating tissue all at the same time.
Shortly after implantation and when results start showing, essentially making it easier for the patient to breathe, quality of life improves in the form of:
• Breathing becomes easier
• Energy and stamina increases
• Bronchial infections become less frequent
Most of our COPD patients require a single implant of cells to achieve the therapeutic effect; however, for non-option patients and pulmonary fibrosis patients, we strongly suggest a minimum of two implants, regardless of how well they feel after the first SCT.
Side Effects – We have not seen any ill side effects, only overall improvements of other unrelated conditions. We strive to educate our patients for them to understand what to expect from treatment.
If you would like to request information on treatment, please click the button below to fill out a quick questionnaire. You’ll be paired with a specialist, knowledgeable in all aspects of our therapies, and you’ll be contacted to discuss your needs shortly.Contact Us